News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,988 Results
Type
Article (15774)
Company Profile (263)
Press Release (280942)
Multimedia
Podcasts (127)
Webinars (13)
Section
Business (90901)
Career Advice (171)
Deals (13534)
Drug Delivery (69)
Drug Development (51113)
Employer Resources (32)
FDA (6017)
Job Trends (5247)
News (146042)
Policy (10099)
Tag
2025 Best Places to Work (13)
2026 Best Places to Work (19)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Standard (3)
40 Under 40 (4)
Academia (980)
Accelerated approval (39)
ADA (34)
Adcomms (16)
Allergies (128)
Alliances (21785)
ALS (204)
Alzheimer's disease (1263)
Antibody-drug conjugate (ADC) (582)
Approvals (6447)
Artificial intelligence (491)
ASCO (224)
Autoimmune disease (410)
Automation (20)
Bankruptcy (112)
Belgium (30)
Best Places to Work (4581)
BIO (56)
Biologics (71)
BIOSECURE Act (6)
Biosimilars (161)
BioSpace Insights (81)
Biotechnology (179)
Bispecific (54)
Bladder cancer (143)
Brain cancer (73)
Breast cancer (514)
Cancer (5052)
Cardiovascular disease (375)
Career advice (175)
Career pathing (15)
CAR-T (347)
CDC (11)
CDMO (127)
Celiac Disease (6)
Cell therapy (889)
Cervical cancer (31)
Clinical research (46654)
Collaboration (1779)
Commercialization (44)
Company closure (4)
Compensation (988)
Complete response letters (73)
COVID-19 (1156)
CRISPR (131)
CRO (4)
C-suite (1057)
Cystic fibrosis (132)
Data (7644)
Denatured (27)
Depression (134)
Dermatology (131)
Diabetes (404)
Diagnostics (1586)
Digital health (21)
Diversity (6)
Diversity, equity & inclusion (9)
Drug discovery (361)
Drug pricing (55)
Drug shortages (4)
Duchenne muscular dystrophy (344)
Earnings (33938)
Editorial (37)
Employer branding (4)
Employer resources (30)
ESMO (311)
Events (55637)
Executive appointments (804)
Eye disease (16)
FDA (8835)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (6)
Friedreich's ataxia (28)
Frontotemporal dementia (36)
Funding (1496)
Gene editing (264)
Generative AI (50)
Gene therapy (725)
GLP-1 (638)
Government (1218)
Grass and pollen (3)
Guidances (182)
Healthcare (6845)
Hematology (144)
HIV (40)
Huntington's disease (75)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (125)
Immunology and inflammation (291)
Immuno-oncology (123)
Indications (191)
Infectious disease (1338)
Inflammatory bowel disease (216)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (263)
Interviews (21)
IPO (7424)
IRA (13)
Job creations (872)
Job search strategy (140)
JPM (41)
Kidney cancer (13)
Kidney disease (126)
Labor market (46)
Layoffs (280)
Leadership (22)
Legal (1407)
Licensing (99)
Liver cancer (54)
Longevity (39)
Lung cancer (701)
Lung diease (21)
Lymphoma (369)
Machine learning (37)
Management (8)
Manufacturing (714)
Marketing (25)
MASH (189)
Medical affairs (4)
Medical device (2765)
Medtech (2820)
Melanoma (110)
Mergers & acquisitions (6996)
Metabolic disorders (1117)
Middle East (1)
mRNA (230)
Multiple sclerosis (162)
Multispecific (6)
NASH (14)
Netherlands (19)
Neurodegenerative disease (433)
Neuropsychiatric disorders (105)
Neuroscience (2780)
Neurotech (2)
NextGen: Class of 2026 (2043)
Non-profit (895)
Now hiring (50)
Obesity (496)
Opinion (161)
Ovarian cancer (232)
Pain (175)
Pancreatic cancer (312)
Parkinson's disease (366)
Partnered (19)
Patents (514)
Patient advocacy (7)
Patient recruitment (682)
Patient selection (93)
Peanut (55)
People (28008)
Peptides (33)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (16518)
Phase 2 (21711)
Phase 3 (13737)
Pipeline (9247)
Policy (114)
Postmarket research (853)
Preclinical (6977)
Press Release (30)
Prostate cancer (247)
Psychedelics (89)
Radioligand (3)
Radiopharmaceuticals (342)
Rare diseases (1133)
Real estate (1464)
Recruiting (12)
Regenerative medicine (24)
Regulatory (11469)
Reports (33)
Research institute (1009)
Resumes & cover letters (20)
Rett syndrome (51)
RNA editing (38)
RSV (26)
Schizophrenia (176)
Series A (295)
Series B (198)
Series C (1)
Service/supplier (2)
Sickle cell disease (110)
Special edition (24)
Spinal muscular atrophy (131)
Sponsored (22)
Startups (2062)
State (1)
Stem cells (7)
Stomach cancer (7)
Substance use disorders (20)
Supply chain (49)
Switzerland (15)
Tariffs (20)
The Weekly (98)
Vaccines (473)
Venture capital (120)
Weight loss (263)
Wet AMD (6)
Women's health (67)
Women in leadership (1)
Worklife (4)
Date
Today (4)
Last 7 days (396)
Last 30 days (2148)
Last 365 days (18407)
2026 (16929)
2025 (18099)
2024 (20483)
2023 (22431)
2022 (26829)
2021 (27828)
2020 (23378)
2019 (16252)
2018 (11760)
2017 (13761)
2016 (11848)
2015 (14367)
2014 (10395)
2013 (7489)
2012 (7534)
2011 (7617)
2010 (7433)
Location
Africa (161)
Alabama (86)
Alaska (2)
Arizona (109)
Arkansas (6)
Asia (19330)
Australia (3329)
California (10491)
Canada (2597)
China (1383)
Colorado (397)
Connecticut (395)
Delaware (364)
Europe (41408)
Florida (1381)
Georgia (289)
Hawaii (3)
Idaho (18)
Illinois (656)
India (78)
Indiana (246)
Iowa (13)
Japan (408)
Kansas (93)
Kentucky (13)
Louisiana (18)
Maine (14)
Maryland (1072)
Massachusetts (8372)
Michigan (143)
Minnesota (362)
Mississippi (4)
Missouri (41)
Montana (17)
Nebraska (6)
Nevada (71)
New Hampshire (22)
New Jersey (2357)
New Mexico (14)
New York (2547)
North Carolina (1214)
North Dakota (9)
Northern California (5450)
Ohio (254)
Oklahoma (12)
Oregon (28)
Pennsylvania (1899)
Puerto Rico (12)
Rhode Island (31)
South America (218)
South Carolina (20)
Southern California (4263)
Tennessee (73)
Texas (1511)
United States (34564)
Utah (145)
Virginia (212)
Washington D.C. (37)
Washington State (850)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
296,988 Results for "prelude therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
November 16, 2026
·
14 min read
Press Releases
Prelude Therapeutics to Participate in the Chardan Healthcare Conference 2026
October 18, 2026
·
1 min read
Press Releases
Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 11, 2026
·
1 min read
Press Releases
Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026
·
11 min read
Press Releases
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader
September 10, 2026
·
4 min read
Press Releases
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering
April 20, 2026
·
5 min read
Press Releases
Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 12, 2026
·
12 min read
Press Releases
Prelude Therapeutics Announces the Appointment of Charles Morris, M.D. as Chief Medical Officer
April 15, 2026
·
5 min read
Press Releases
Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer
October 13, 2026
·
6 min read
Press Releases
Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026
March 10, 2026
·
12 min read
1 of 29,699
Next